Ritalin: Drug Control

What is Attention-Deficit/Hyperactivity Disorder (with or without hyperactivity)?

For many laboratories are using this condition (for many invented in order to introduce a drug to control the total population), and beginning to create addicts from very early ages. Begin to read about this drug, one of the most dangerous for human freedom, precisely because legal. Remember the book "1984", "Brave New World? and the film "The Matrix?. All this may be happening today in front of your nose!

Methylphenidate (MFD) is a psychostimulant, better known by the brand name Ritalin (in Hispanic countries: Ritalin). The MFD has existed for over 60 years. However, special notoriety gained from the nineties. This was because the diffusion of the diagnosis of attention deficit disorder with hyperactivity (ADHD) in children and adults, a phenomenon linked to the requirement in MFD, drug of choice for this treatment. As an example, Concerta (one of the many brands of MFD) in the U.S. reached. UU. sales volumes in excess of $ 839 million in 2005.

Both the diagnosis and the drug has been challenged, even by appealing to ethical principles, ideological or religious. Such rejection has been attributed to moral panic reactions of the lay public to the concept of drug treatment in children, or beliefs (often unfounded) about the consequences. The subject occupied the mass media, speaking figures of psychoanalysis and antipsychiatry. This was the case of Scientology, a religious cult with interference in scientific matters.

The criticisms of ADHD and methylphenidate become, often of a general rejection of the concept of neurobiological dysfunction and neurochemical assumptions that underlie the practice of contemporary psychiatry.

Ciba Pharmaceutical Company (precursor to Novartis) launched the product to market in 1955 under the name Ritalin. Since its inception, was used for a variety of indications. The Physician's Desk Reference, 1957 further alleged that he was "indicated in chronic fatigue and lethargic and depressive states, including those associated with anesthetic agents and other drugs, senile disturbed behavior, psychoneurosis and psychosis associated with depression?.

In the early sixties, popularized the use of MFD to treat children with ADHD syndrome known at the time as "hyperactivity? or "minimal brain dysfunction? (DCM). In those years, the growing popularity could also Ritalin because of newspaper endorsements on their current use among celebrities from the worlds of politics and science, as astronaut Buzz Aldrin, and the mathematician Paul Erdős.

In 1969, the Church of Scientology, founded the so-called Citizens Commission on Human Rights (CCHR). A few months later, he would begin an open campaign, using the mass media, as opposed to psychiatric medication in general, and Ritalin in particular.

In 1971, the International Convention on Psychotropic Substances to the MFD included in Schedule II.

MFD is currently the most commonly prescribed medication to treat ADHD around the world. According to estimates, over 75% of prescriptions for children are made MFD, with this disorder four times more common among boys than girls. Production and prescription of the MFD grew significantly in the nineties, especially in the United States, to the extent that the diagnosis of ADHD became better understood and more widespread acceptance within the medical and mental health.

Some of the best known critics are Peter Breggin, Thomas Armstrong, Fred Baughman and journalist Thom Hartmann, famous for his "theory of the farmer and the hunter? to characterize ADHD. They argue that the observed neurobiological characteristics are not necessarily of pathological origin, and become upset by changes in behavior associated with the use of stimulants.

It is estimated that the gross value of annual output of MFD in 2005, have multiplied at least seventeen the 1990 level, according to figures provided for the current year in the U.S.. UU., Happening at that period of less than 2 tons to over 30. The MFD is currently under international control psychotropic wider distribution in the legal circuit. It has become a more profitable manufacturing for pharmaceutical industrial complex. Income from the market for ADHD drugs, including the MFD and its competitors, reach only in the U.S.. UU. values ​​greater than the 3,100 million dollars. Note that the annual gross domestic product from about 50 countries would be below those figures.